logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
      • Extra General Meeting, August 2022
      • Annual General Meeting 2022
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Financial Reports and Presentations

All categories
  • Annual reports
All years
  • 2022
  • 2021
  • 2020
All languages
  • English
  • Swedish
2022

Årsredovisning 2021

Read more
2022

Annual Report 2021

Read more
2021

Årsredovisning 2020

Read more
2021

Annual Report 2020

Read more
2020

Årsredovisning 2019

Read more
2020

Annual Report 2019

Read more
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
      • Extra General Meeting, August 2022
      • Annual General Meeting 2022
    • Calendar
    • Press Releases

IR contact

Anders Karlsson
Anders Karlsson
Chief Executive Officer
+46 70 - 918 00 10
[email protected]

Subscribe

CONTACT

Anders Karlsson
Chief Executive Officer
Phone +46 70 – 918 00 10
[email protected]

All contacts

VISITING ADDRESS

Karolinska Institutet Science Park
Fogdevreten 2
SE – 171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in Umeå
Reg no 556698-3655

  • Cookies
  • Privacy Policy